Rep. La Shawn Ford

Amends the Overdose Prevention and Harm Reduction Act. Provides that a pharmacist may sell fentanyl test strips over-the-counter to the public to test for the presence of fentanyl, a fentanyl analogue, or a drug adulterant within a controlled substance. Provides that a county health department may distribute fentanyl test strips at the county health department facility for no fee. Amends the Drug Paraphernalia Control Act. Provides that "drug paraphernalia" does not include equipment, products, or materials to analyze or test for the presence of fentanyl, a fentanyl analogue, or a drug adulterant within a controlled substance.

Amends the Illinois Works Jobs Program Act. Provides that the Illinois Works Review Panel's examination of workforce demographic data collected by the Illinois Department of Labor must include demographic information about the workforce on public work projects contracted by the State or an agency of the State by contractor, race, gender, trade, hours worked by payroll cycle and annually, whether apprentice or journeyworker, and, if an apprentice, which year of apprenticeship, and whether or not the apprentice is a graduate of the Illinois Works Preapprenticeship Program. Provides that individual members of the workforce shall be given a unique identifier so that progress and retention can be tracked without sharing personally identifiable information. Creates the Access and Opportunity Committee to monitor and report on the progress of ensuring that all Illinois residents have access to careers in the construction industry and building trades on current State capital projects, including those who have been historically underrepresented in those trades. Includes provisions regarding Committee membership, powers and duties, and meetings.

Amends the Department of Employment Security Law. Directs the Department of Employment Security to work with the Department of Healthcare and Family Services to identify employment opportunities in the State for persons who are in arrears in child support obligations.

Amends the Courses of Study Article of the School Code. Provides that school districts shall provide instruction on the dangers of fentanyl. Specifies the elements of the instruction. Provides that students shall be assessed on the fentanyl instruction.

Amends the Unified Code of Corrections. Provides that a person on probation, conditional discharge, or supervision shall not be ordered to refrain from having cannabis or alcohol in his or her body unless the person was sentenced to probation, conditional discharge, or supervision for an offense which had as an element of the offense the presence of an intoxicating compound in the person's body or the person is participating in a Problem-Solving Court certified by the Administrative Office of the Illinois Courts. Provides that for each condition imposed, the court shall state the reasonable relation the condition has to the person's crime of conviction. Provides that a person on probation, conditional discharge, or supervision shall not be ordered to refrain from use or consumption of any substance lawfully prescribed by a medical provider or authorized by the Compassionate Use of Medical Cannabis Program Act.

Amends the School Code. Provides that, in consultation with education stakeholders, the State Board of Education shall develop and adopt a comprehensive literacy plan for the State on or before October 1, 2023. Effective immediately.

Amends the Prevailing Wage Act. Provides that the definition of "public works" includes power washing projects in which steam or pressurized water, with or without added abrasives or chemicals, is used to remove paint or other coatings, oils or grease, corrosion, or debris from a surface or to prepare a surface for a coating.

Amends the Community-Law Enforcement and Other First Responder Partnership for Deflection and Substance Use Disorder Treatment Act. Changes the Act name to the Community Partnership for Deflection and Substance Use Disorder Treatment Act. Modifies and adds definitions. Provides that A law enforcement agency, other first responder entity, or local government agency (rather than only a law enforcement agency or other first responder entity) may establish a deflection program in partnership with one or more licensed providers of substance use disorder treatment services and one or more community members or organizations. Provides that a deflection program may involve a pre-arrest diversion response and proactive identification of persons thought likely to have an untreated or undiagnosed mental illness. Provides that a local deflection program shall also include case management and restorative justice aspects. Provides that a deflection program may accept, receive, and disburse, in furtherance of its duties and functions, any funds, grants, and services made available by the State and its agencies, the federal government and its agencies, units of local government, and private or civic sources. Provides that activities eligible for funding under the Act include naloxone and related harm reduction supplies (rather than related supplies) necessary for carrying out overdose prevention and reversal (rather than overdose reversal) for purposes of distribution to program participants or for use by law enforcement, other first responders, or local governmental agencies and wraparound participant funds to be used to incentivize participation and meet participant needs. Provides that the Legislative Reference Bureau shall reassign the Act in the Illinois Compiled Statutes (to reflect the addition of local government agencies to the Act).

Creates the Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act. Provides that a manufacturer or wholesale drug distributor shall not engage in price gouging in the sale of an essential off-patent or generic drug. Provides that the Director of Healthcare and Family Services or Director of Central Management Services may notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the State’s Medical Assistance Program or a State health plan, respectively, that amounts to price gouging. Provides that whenever the Attorney General has reason to believe that a manufacturer or wholesale drug distributor of an essential off-patent or generic drug has violated the Act, the Attorney General shall send a notice to the manufacturer or wholesale drug distributor requesting a specified statement. Provides that within 45 days after receipt of the request, the manufacturer or wholesale drug distributor shall submit the statement to the Attorney General. Provides that to accomplish the objectives and carry out the duties prescribed in the Act, the Attorney General may issue subpoenas or examine under oath any person to determine whether a manufacturer or wholesale drug distributor has violated the Act. Provides that upon petition of the Attorney General, a circuit court may issue specified orders against violations of the Act. Contains provisions concerning the disclosure of financial information provided by a manufacturer or wholesale drug distributor to the Attorney General. Effective January 1, 2024.

Amends the Drug Paraphernalia Control Act. Makes a technical change in a Section concerning the short title.